Valley Brook Capital Group’s Novartis NVS Stock Holding History

Valley Brook Capital Group’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$739K	Sell	4,717 -50	-1%	-$7.5K	0.42%	62
2026 Q1	$728K	Hold	4,767	–	–	0.49%	55
2025 Q4	$657K	Sell	4,767 -192	-4%	-$25.1K	0.43%	55
2025 Q3	$636K	Hold	4,959	–	–	0.43%	57
2025 Q2	$600K	Hold	4,959	–	–	0.45%	57
2025 Q1	$553K	Hold	4,959	–	–	0.43%	56
2024 Q4	$483K	Hold	4,959	–	–	0.36%	62
2024 Q3	$570K	Hold	4,959	–	–	0.41%	61
2024 Q2	$528K	Sell	4,959 -25	-0.5%	-$2.51K	0.41%	61
2024 Q1	$482K	Hold	4,984	–	–	0.39%	61
2023 Q4	$503K	Hold	4,984	–	–	0.44%	57
2023 Q3	$508K	Hold	4,984	–	–	0.5%	56
2023 Q2	$503K	Hold	4,984	–	–	0.46%	60
2023 Q1	$459K	Hold	4,984	–	–	0.42%	62
2022 Q4	$452K	Hold	4,984	–	–	0.43%	63
2022 Q3	$378K	Hold	4,984	–	–	0.41%	66
2022 Q2	$421K	Hold	4,984	–	–	0.43%	64
2022 Q1	$437K	Sell	4,984 -167	-3%	-$14.5K	0.38%	69
2021 Q4	$450K	Hold	5,151	–	–	0.39%	68
2021 Q3	$421K	Hold	5,151	–	–	0.42%	64
2021 Q2	$469K	Hold	5,151	–	–	0.45%	60
2021 Q1	$440K	Hold	5,151	–	–	0.4%	56
2020 Q4	$486K	Buy	+5,151	New	+$450K	0.48%	52

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TAM

Todd Asset Management Louisville, Kentucky $5.63B AUM 45.28% 1-Year Est. Return

Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

CPC

Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

Valley Brook Capital Group's NVS Position: Q2 2026 in Review

Valley Brook Capital Group reduced its Novartis (NVS) stake by 1% in Q2 2026, selling an estimated $7.5K and leaving 4,717 shares worth $739K. The position accounts for 0.42% of the portfolio, ranked #62.

Valley Brook Capital Group first reported a position in NVS in Q4 2020 and has held it in 23 quarters since. 948 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

Valley Brook Capital Group held 4,717 shares of Novartis worth $739K as of Q2 2026.
Valley Brook Capital Group sold 50 Novartis shares in Q2 2026, an estimated $7.5K.
Novartis made up 0.42% of Valley Brook Capital Group's portfolio in Q2 2026, its #62 holding.
Valley Brook Capital Group first reported a position in Novartis in Q4 2020 and has held it in 23 quarters since.
948 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Valley Brook Capital Group's 13F filing for Q2 2026, filed 27 Jul 2026.